AVIAN FLU BREAKTHROUGH

Added: (Wed Feb 22 2006)

Pressbox (Press Release) - ALLIANCE TECHNOLOGY today announces the most significant scientific breakthrough to date in preventing the spread of lethal infections including Avian Bird Flu, MRSA and SARS.
Activ8, launched today, is the first non-toxic cleaner disinfectant. It is scientifically proven to be highly effective against a wide spectrum of bacteria, viruses and fungi including: Avian Bird Flu, SARS, MRSA, Noro Virus, Hepatitis B/C and Tuberculosis.
Activ8 offers powerful cleaning and protection in a single, non-toxic, environmentally safe product suitable for medical, commercial or household use. Activ8 is ideal for use in the front line of infection control, with applications ranging from preventing the spread of MRSA and other superbugs in hospitals to stopping the spread of Avian Bird Flu, SARS and other pandemics in public places.
Andrew Platts Managing Director of Alliance Technology , said: “Activ8 is the product of a twenty-year research programme to realise the vision of total bacterial, fungal and viral disinfection. This is the killer application we have been searching for; as well as being a powerful and non-toxic cleaner, it kills our most feared and dangerous infections. We aim to turn the cleaning industry on its head – with a product as powerful and safe as Activ8 - why would anyone use any other cleaner?”
Activ8 is packaged as floor cleaner, surface cleaner, impregnated wipes and liquid soap and can also be used in vaporizers for cleaning and decontaminating large air spaces. The product is safe for use with no special precautions because it is as non-toxic as ordinary household soap.
The product is available to medical and commercial customers in the UK with immediate effect. Alliance is actively seeking commercial partners to make the product available to consumers and open up further global markets.
About Activ8
Activ8 works by irreversibly binding, penetrating and immobilising bacteria, viruses and fungi so that they cannot replicate, leaving surfaces disinfected and safe to use. In addition to providing powerful infection control for clinical environments such as hospitals, clinics, dental surgeries and nursing homes, Activ8’s powerful cleaning and disinfecting properties make it ideal for use in any environment where good hygiene is important – from schools, leisure centres, offices, supermarkets and catering/food preparation areas to hotels, airports and aircraft, cruise ships and oil rigs.
Activ8’s ability to kill Avian Bird Flu and other bacteria and viruses within minutes of contact make it an ideal tool to help farmers protect poultry and other livestock from the spread of disease. The product’s powerful anti-fungal properties can also be used to protect timber and timber frame construction housing.
Activ8’s effectiveness has been proven in rigorous scientific trials from bodies including the Centre for Infectious Diseases, Queen Mary’s School of Medicine; the Hospital Infection Research Laboratory, Birmingham; Safepharm Ltd and the Health Protection Agency Regional Laboratory, Bristol.
John Oxford, Professor of Virology at Queen Mary’s School of Medicine and Scientific Director of Retroscreen Virology, who conducted the tests on Avian Bird Flu and SARS said: “Following rigorous testing in our laboratory I am happy to confirm that Activ8 is highly effective against two very important and dangerous viruses, Avian Bird Flu and SARS. With a 99.9% kill rate, we believe that the Activ8 product could have a significant impact on destroying these viruses in public places, on farms and in the home.”
Adam Fraise, Director of the Hospital Infection Research Laboratory, Birmingham, said: “Our tests demonstrate that this product is effective against MRSA within one minute of impact; reducing the number of live MRSA organisms by more than 100,000 times.”
Jean Lawrence, Chair, of the UK Infection Control Nurses Association (ICNA), said: “A product that is non-toxic and effective against MRSA could offer significant benefits including the ability to decontaminate wards and other clinical settings without expensive closures. Hospitals and community healthcare environments face significant challenges in the battle against MRSA and other micro-organisms. Obviously a product which is non-toxic and environmentally friendly is safer for use in areas where patient care is being carried out.”
Christine Perry, former head of the UK Infection Control Nurses Association, said: “Activ8 has the potential to have a significant impact on the growing challenge of infection control and prevention worldwide. In addition to making important contribution to the fight against hospital acquired infection, this product has potential to be used in both public and private spaces to help prevent the spread of pandemics like Avian Bird Flu and SARS, and maintain a clean and safe environment.”